Recorded Chinese product: 酚磺乙胺注射液酚磺乙胺注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 国药集团容生制药有限公司Chinese legal name: 国药集团容生制药有限公司
主要成分Active Ingredients
- 依地酸二钠Yidi Suaner Na
- 注射用水Water for Injection (注射用水)
- 酚磺乙胺Fenhuang Yian
药物知识说明
依地酸二钠是一种在国家药监局注册认定的药品。该药品含有依地酸二钠、注射用水、酚磺乙胺-ed5b2952等成分。
该药品关联的活性成分包括：依地酸二钠Yidi Suaner Na、注射用水、酚磺乙胺Fenhuang Yian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：国药集团容生制药有限公司Chinese legal name: 国药集团容生制药有限公司。
您可以探索含有相同成分的其他药品：依地酸二钠-e06955e8成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 酚磺乙胺注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 依地酸二钠Yidi Suaner Na, 酚磺乙胺Fenhuang Yian.
Manufacturers recorded for this product: 国药集团容生制药有限公司Chinese legal name: 国药集团容生制药有限公司.
Explore other medicines containing the same ingredient: 依地酸二钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 酚磺乙胺注射液Recorded Chinese product: 酚磺乙胺注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml：0.5g2 mL:0.5 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 国药集团容生制药有限公司Chinese legal name: 国药集团容生制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20057257
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20057257
Manufacturer
Chinese legal name: 国药集团容生制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20057257
生产企业
国药集团容生制药有限公司(国产)
适应症
防治各种手术前后的出血，也可用于血小板功能不良、血管脆性增加而引起的出血，亦可用于呕血、尿血等。
用法用量
1．肌内注射或静脉注射：一次0.25-0.5g，一日0.5-1.5g。静脉滴注：一次0.25-0.75g，一日2-3次，稀释后滴注。2．预防手术后出血术前15-30分钟静滴或肌注0.25-0.5g，必要时2小时后再注射0.25g。
不良反应
本品毒性低，可有恶心、头痛、皮疹、暂时性低血压等，偶有静脉注射后发生过敏性休克的报道。
禁忌
未进行该项实验且无可靠参考文献。
注意事项
1、本品可与维生素K注射液混合使用，但不可与氨基己酸注射液混合使用。||2、如遇变色、结晶、浑浊、异物应禁用。
贮藏
遮光，密闭保存。
规格
2ml：0.5g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.